Understanding the warning signs, risk factors and available treatments is crucial for early detection, effective treatment ...

Venous thromboembolism (VTE) is a common complication among patients with cancer. Increased risk of VTE is associated with certain cancer types, advanced disease, surgery, chemotherapy and ...

Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning medication for at least six months, followed by an additional 12 ...

CHICAGO -- For extended anticoagulation after venous thromboembolism (VTE) in patients with active cancer, a lower dose of apixaban (Eliquis) was just as effective as a higher dose -- and safer ...

[14] Well-documented risk factors for VTE development include surgery, trauma, immobility, cancer, increasing age, obesity, and acute medical illness, and many hospitalized patients have at least ...

This will lead the nation in collecting meaningful data that will shape research and policy for many decades to come.' ...

DVTs and PEs together are sometimes called venous thromboembolism (VTE ... has moved to your lungs (a pulmonary embolism), the symptoms include: People with cancer have a higher risk of developing ...

Patients with cancer and VTE are at risk for VTE recurrence, and there are limited data on appropriate and effective anticoagulation regimens beyond 6 months. New research findings are summarized ...

The VTE rate ratios were significantly greater for ... including thrombosis, cancer, thrombophilia, liver or kidney disease, infertility treatment, or hormone therapy, were included.